RECKITT BENCKISER GROUP PLC ORD GBP0.10

Symbol: RKT

This security went ex-dividend on 10/04/2025. Pay date is 29/05/2025

Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.

Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.

Invest in this share within an ISA, JISA, SIPP or Investment Account

Overview

Core Data
Latest Dividend Information

Ex-Dividend Date 10 Apr 2025
Pay Date 29 May 2025
Total Dividends - Year to Date202.1
Dividend Yield (%)4.0615

Historical Data & Ratios

Avg Volume Over 10 Days2.3479
Market Cap (M)31572.2400
Price/Earnings (PE)0
Earnings Per Share202.86
Revenue Per Share20.1912
Return on Equity %18.8816

1 Month Performance Chart

One Month Chart

Broker View
Data shown is based on the past 75 days of broker views.

ActionBrokers

Strong Buy4

Buy5

Neutral10

Sell0

Strong Sell0

Brokers 4 5 10 0 0
Consensus

ConsensusBuy

Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.

Cost and Charges Information

This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product

Account Type

  • Investment Account
  • Stocks & Shares ISA
  • SIPP

Annual charges

These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate

Cost Category % of Investment lump sum costs
Our annual fee

Our annual fee

Includes our platform fee at 0.30% per annum (excluding Charles Stanley Multi Asset Funds and anycash held). The min fee is £60, the max is £600 per annum, plus SIPP administration fee (if applicable, only charged if < £30,000 held) – see here
0.30%
Dealing charges

Dealing charges

Any one-off commission charges associated with investing. Note that government taxes and levies are not included. This does not include any commission credits you may have available
N/A
Product provider costs

Product provider costs

Product provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs
N/A N/A
Total (£)

Total (£)

Costs per annum displayed in monetary value
Total (%)

Total (%)

Costs per annum displayed as a percentage of investment value

Cumulative effect of charges on your investment's return

This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges

lump sum invested with an assumed growth rate of 1 year years
What you might get back at  with no charges applied

What you might get back at  with no charges applied

These are the illustrative values of a  investment after growth and no costs applied at the end of the defined period
Annual charges

Annual charges

These are the annual costs based on an initial investment amount of assuming a net zero growth rate
Effect of charges on return (%)

Effect of charges on return (%)

These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate
Effect of charges on return (£)

Effect of charges on return (£)

These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate
What you might get back at with charges applied

What you might get back at with charges applied

These are the illustrative values of a investment after growth and costs at the end of the defined period

This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use

Charts

  • Chart Options

    Select Timeframe Add a sector as a comparator Add an index as a comparator Add a share as a comparator

      Add a moving average as a comparator Add a lower indicator as a comparator Chart Style Current Comparators

      Company

      Business Summary

      Reckitt Benckiser Group PLC (Reckitt) is a United Kingdom-based global consumer goods company. The Company's operating segments comprise the Hygiene, Health, and Nutrition business. The Hygiene portfolio works to eliminate dirt, germs, pests, and odors with products such as Lysol, Finish, Air Wick, Harpic and Mortein. The Company’s Health portfolio offers various solutions that provide pain relief, protection, hygiene, and personal care to households across the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, Strepsils and Veet. The Nutrition business includes its infant and child nutrition, its adult nutrition and its range of vitamins, minerals, and supplements (VMS). Brands under Nutrition business include Enfa, Enfamil, Nutramigen, Airborne, Move Free and Neuriva. The Company’s brands also include Dettol, Lysol, Harpic, Finish, Durex, Mucinex, Enfamil and Move Free and more.

      Financial Summary

      BRIEF: For the fiscal year ended 31 December 2024, Reckitt Benckiser Group Plc revenues decreased 3% to £14.17B. Net income before extraordinary items decreased 12% to £1.43B. Revenues reflect Nutrition segment decrease of 11% to £2.15B, Health segment decrease of 3% to £5.88B, US segment decrease of 8% to £4.18B, World-United Kingdom -United States -China (Country) segment decrease of 1% to £9.1B, Comparable Store Sales Growth decrease of 83% to -7.3%.

      Financials


      Income Statement - All values are in GBP (M).

      Year Ending

      31/12/2024

      31/12/2023

      31/12/2022

      31/12/2021

      31/12/2020

      31/12/2019

      Total Revenue 14,169.00 14,607.00 14,453.00 13,234.00 13,993.00 12,846.00
      Gross profit 8,595.00 8,760.00 8,361.00 7,679.00 8,435.00 7,778.00
      Operating Profit/Loss 2,425.00 2,531.00 3,228.00 -807.00 2,159.00 -1,954.00
      Profit Before Tax 2,104.00 2,401.00 3,067.00 -260.00 1,873.00 -2,107.00
      Profit After Tax 1,432.00 1,648.00 2,356.00 -52.00 1,153.00 -2,772.00
      Equity Holders of Parent Company 1,426.00 1,643.00 2,330.00 -32.00 1,187.00 -3,683.00
      Minority Interest 19.00 7.00 21.00 43.00 28.00 31.00


      Balance Sheet - All values are in GBP (M).

      Year Ending

      31/12/2024

      31/12/2023

      31/12/2022

      31/12/2021

      31/12/2020

      31/12/2019

      Total Non-Current Assets 20,700.00 21,834.00 23,457.00 21,941.00 25,978.00 27,106.00
      Total Current Assets 4,598.00 5,302.00 5,285.00 5,005.00 5,314.00 5,033.00
      Total Assets 25,298.00 27,136.00 28,742.00 26,946.00 31,292.00 32,139.00
      Total Liabilities 18,578.00 18,667.00 19,259.00 19,493.00 22,133.00 22,732.00
      Total Net Assets 6,720.00 8,469.00 9,483.00 7,453.00 9,159.00 9,407.00
      Shareholders Funds 6,699.00 8,448.00 9,443.00 7,399.00 9,115.00 9,363.00
      Minority Interests 19.00 7.00 21.00 43.00 28.00 31.00
      Total Equity 6,720.00 8,469.00 9,483.00 7,453.00 9,159.00 9,407.00

      Outlook

      Broker View
      Data shown is based on the past 75 days of broker views.

      ActionBrokers

      Strong Buy4

      Buy5

      Neutral10

      Sell0

      Strong Sell0

      Brokers 4 5 10 0 0
      Consensus

      ConsensusBuy

      Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.

      © 2022 Refinitiv, an LSEG business. All rights reserved.

      Forecasts

      Year 2025 2026 2027
      Revenue £14,276.10mn £14,778.40mn £15,330.20mn
      Pre-tax-Profit £3,429.94mn £3,617.44mn £3,767.56mn
      EPS £3.44p £3.68p £3.93p
      EPS Growth -1.68% 7.16% 6.64%
      P/E 14.2 13.22 12.39
      PEG Ratio -8.44 1.85 1.87
      Dividend 208.72p 220.36p 233.12p
      Yield 0.00% 0.00% 0.00%

      Upgrades & Downgrades (Latest)

      DateBrokerRecommendationPriceOld TargetNew TargetChange
      23rd Oct 2024Berenberg BankReiteration4953p5200p5177pHold
      30th Aug 2024JP Morgan CazenoveDownGrade4366p0p0pNeutral
      29th Jul 2024JefferiesReiteration4093p0p4400pHold
      24th Jul 2024Berenberg BankReiteration4493p5100p5200pHold
      18th Apr 2024HSBCReiteration4139p0p0pHold

      Time & Sales

      All prices are in GBX and times are in GMT. Last 20 trades shown. Trade type is estimated and should be treated as indicative only.

      Date Time Price Volume Type
      2 May 2025 18:29 4,976 68 Buy
      2 May 2025 16:48 4,976 753 Buy
      2 May 2025 16:39 4,976 100 Sell
      2 May 2025 16:39 4,976 5,000 Sell
      2 May 2025 16:39 4,976 500 Sell
      2 May 2025 16:39 4,976 500 Sell
      2 May 2025 16:39 4,976 5,288 Sell
      2 May 2025 16:35 4,976 770 Unknown
      2 May 2025 16:35 4,976 1,898 Unknown
      2 May 2025 16:35 4,976 570,115 Unknown
      2 May 2025 16:32 4,952 1 Unknown
      2 May 2025 16:29 4,978 33 Buy
      2 May 2025 16:29 4,978 31 Buy
      2 May 2025 16:29 4,975 39 Sell
      2 May 2025 16:29 4,975 33 Sell
      2 May 2025 16:29 4,975 36 Sell
      2 May 2025 16:29 4,975 29 Sell
      2 May 2025 16:29 4,975 163 Sell
      2 May 2025 16:29 4,977 32 Buy
      2 May 2025 16:29 4,977 37 Buy

      Selected data supplied by Thomson Reuters ©  View restrictions.

      VIEW ALL MARKET NEWS

      Investment involves risk. You may get back less than invested.